{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:59:35Z","timestamp":1784807975185,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06139-6","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:43:59Z","timestamp":1765953839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of NOACs in patients undergoing water vapour thermal therapy (REZUM) for benign prostatic obstruction: a comprehensive review"],"prefix":"10.1007","volume":"44","author":[{"given":"M.","family":"Coscarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Al Barajraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dalati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fourmarier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Roumegu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cindolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"6139_CR1","doi-asserted-by":"publisher","unstructured":"Franco A, Ditonno F, Manfredi C, Bologna E, Licari LC, Orecchia L, Finazzi Agr\u00f3 E, Antonelli A, Arlandis S, Autorino R, Tarcan T, Cornu JN, Elterman D, Kaplan S, Lombardo R, McVary K, Secco S, Cindolo L, De Nunzio C Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2025 Sep 17:S0302-2838(25)00492-0. https:\/\/doi.org\/10.1016\/j.eururo.2025.09.004. Epub ahead of print. PMID: 40967932","DOI":"10.1016\/j.eururo.2025.09.004"},{"issue":"6","key":"6139_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","volume":"79","author":"S Malde","year":"2021","unstructured":"Malde S, Umbach R, Wheeler JR, Lytvyn L, Cornu J\u2013N, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Gravas S, Drake MJ, Guyatt GH, Tikkinen KAO (2021) A systematic review of patients\u2019 values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms. Eur Urol 79(6):796\u2013809. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.019","journal-title":"Eur Urol"},{"issue":"3","key":"6139_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG (2021) Final 5\u2013year outcomes of the multicenter randomized sham\u2013controlled trial of Rez\u016bm\u2122 water vapor thermal therapy for treatment of moderate\u2013to\u2013severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 206(3):715\u2013724. https:\/\/doi.org\/10.1097\/JU.0000000000001778","journal-title":"J Urol"},{"issue":"3","key":"6139_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/luts.12435","volume":"14","author":"M Babar","year":"2022","unstructured":"Babar M, Loloi J, Tang K, Syed U, Ciatto M (2022) Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review. Low Urin Tract Symptoms 14(3):140\u2013154. https:\/\/doi.org\/10.1111\/luts.12435","journal-title":"Low Urin Tract Symptoms"},{"issue":"2","key":"6139_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.23736\/S2724-6051.22.05080-7","volume":"75","author":"L Cindolo","year":"2023","unstructured":"Cindolo L et al (2023) One-year outcomes after water vapor thermal therapy for symptomatic benign prostatic hyperplasia in an unselected Italian multicenter cohort. Minerva Urol Nephrol 75(2):203\u2013209. https:\/\/doi.org\/10.23736\/S2724-6051.22.05080-7","journal-title":"Minerva Urol Nephrol"},{"issue":"2","key":"6139_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41391-022-00587-6","volume":"26","author":"D Campobasso","year":"2023","unstructured":"Campobasso D et al (2023) Composite urinary and sexual outcomes after rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostatic Dis 26(2):410\u2013414. https:\/\/doi.org\/10.1038\/s41391-022-00587-6","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"6139_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.euf.2023.03.004","volume":"9","author":"M Baboudjian","year":"2023","unstructured":"Baboudjian M, Cornu JN, Gondran\u2013Tellier B, Fourmarier M, Robert G, Peyronnet B, Misrai V, Pradere B (2023) Pharmacologic and surgical retreatment after office\u2013based treatments for benign prostatic hyperplasia: a systematic review. Eur Urol Focus 9(5):727\u2013733. https:\/\/doi.org\/10.1016\/j.euf.2023.03.004","journal-title":"Eur Urol Focus"},{"issue":"1","key":"6139_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41391-023-00669-z","volume":"27","author":"DD Nguyen","year":"2024","unstructured":"Nguyen DD, Li T, Ferreira R, Baker Berjaoui M, Nguyen AV, Chughtai B, Zorn KC, Bhojani N, Elterman D (2024) Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis 27(1):22\u201328. https:\/\/doi.org\/10.1038\/s41391-023-00669-z","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"6139_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00345-022-04258-y","volume":"41","author":"T Spinos","year":"2023","unstructured":"Spinos T, Katafigiotis I, Leotsakos I, Grivas N, Zabaftis C, Ermidis D, Sfoungaristos S, Karavitakis M (2023) Rez\u016bm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostatic hyperplasia: a systematic review of the literature. World J Urol 41(2):413\u2013420. https:\/\/doi.org\/10.1007\/s00345-022-04258-y","journal-title":"World J Urol"},{"key":"6139_CR10","doi-asserted-by":"publisher","unstructured":"Minore A, Morselli S, Franzoso F, Maruzzi D, Varvello F, Toso S, Ferrari G, Siena G, Conti E, Papalia R, Uricchio F, Balsamo R, Scarpa RM, Cindolo L (2024) Is water vapor thermal therapy safe and feasible in elderly and frail men? The Italian experience. World J Urol 42(1):\u2013. https:\/\/doi.org\/10.1007\/s00345-023-04762-9","DOI":"10.1007\/s00345-023-04762-9"},{"issue":"9","key":"6139_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40266-024-01138-5","volume":"41","author":"JR Spruit","year":"2024","unstructured":"Spruit JR, de Vries TAC, Hemels MEW, Pisters R, de Groot JR, Jansen RWMM (2024) Direct oral anticoagulants in older and frail patients with atrial fibrillation: a decade of experience. Drugs Aging 41(9):725\u2013740. https:\/\/doi.org\/10.1007\/s40266-024-01138-5","journal-title":"Drugs Aging"},{"issue":"22","key":"6139_CR12","doi-asserted-by":"publisher","first-page":"e026723","DOI":"10.1161\/JAHA.122.026723","volume":"11","author":"AM Navar","year":"2022","unstructured":"Navar AM, Kolkailah AA, Overton R, Shah NP, Rousseau JF, Flaker GC, Pignone MP, Peterson ED (2022) Trends in oral anticoagulant use among 436,864 patients with atrial fibrillation in community practice, 2011 to 2020. J Am Heart Assoc 11(22):e026723. https:\/\/doi.org\/10.1161\/JAHA.122.026723","journal-title":"J Am Heart Assoc"},{"key":"6139_CR13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"6139_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"6139_CR15","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"6139_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"-VTE Hokusai","year":"2013","unstructured":"Hokusai -VTE, Investigators, B\u00fcller HR, D\u00e9cousus H et al (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369:1406\u20131415","journal-title":"N Engl J Med"},{"key":"6139_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"issue":"1","key":"6139_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","volume":"127","author":"J Kornej","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB (2020) Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res 127(1):4\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"},{"key":"6139_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","volume":"131","author":"BA Steinberg","year":"2015","unstructured":"Steinberg BA, Peterson ED, Kim S et al (2015) Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circulation 131:488\u2013494","journal-title":"Circulation"},{"issue":"10","key":"6139_CR20","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al (2021) 2021 European heart rhythm association practical guide on the use of non\u2013vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 23(10):1612\u20131676. https:\/\/doi.org\/10.1093\/europace\/euab065","journal-title":"Europace"},{"issue":"6","key":"6139_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40256-014-0092-1","volume":"14","author":"TI Verhoef","year":"2014","unstructured":"Verhoef TI, Redekop WK, Hasrat F, de Boer A, \u2013van der Maitland AH (2014) Cost\u2013effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings. Am J Cardiovasc Drugs 14(6):451\u2013462.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"6139_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.eururo.2017.10.035","volume":"73","author":"KAO Tikkinen","year":"2018","unstructured":"Tikkinen KAO, Craigie S, Guyatt GH et al (2018) Procedure\u2013specific risks of thrombosis and bleeding in urological non\u2013cancer surgery: systematic review and meta\u2013analysis. Eur Urol 73(2):236\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2017.10.035","journal-title":"Eur Urol"},{"issue":"2","key":"6139_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bju.15653","volume":"130","author":"JVA Franco","year":"2022","unstructured":"Franco JVA, Jung JH, Imamura M, Borofsky M, Omar MI, Escobar Liquitay CM et al (2022) Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU Int 130(2):142\u2013156. https:\/\/doi.org\/10.1111\/bju.15653","journal-title":"BJU Int"},{"key":"6139_CR24","unstructured":"EAU Guidelines Edn. presented at the EAU Annual Congress Paris April 2024. ISBN 978-94-92671-23-3"},{"issue":"12","key":"6139_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1756287218811037","volume":"10","author":"M Coscarella","year":"2018","unstructured":"Coscarella M, Motte S, Dalati MF, Oliveira\u2013e\u2013Silva T, Entezari K, Roumegu\u00e8re T (2018) New oral anti\u2013coagulation drugs and prostate biopsy: a call for guidelines. Ther Adv Urol 10(12):437\u2013443. https:\/\/doi.org\/10.1177\/1756287218811037","journal-title":"Ther Adv Urol"},{"key":"6139_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1464-410X.2011.10821.x","volume":"110","author":"A Gupta","year":"2012","unstructured":"Gupta A, Streiff M, Resar J et al (2012) Stent management in elective genitourinary surgery. BJU Int 110:480\u2013484","journal-title":"BJU Int"},{"key":"6139_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.juro.2014.04.103","volume":"192","author":"DJ Culkin","year":"2014","unstructured":"Culkin DJ, Exaire EJ, Green D et al (2014) Anticoagulation and antiplatelet therapy in urological practice: ICUD\/AUA. J Urol 192:1026\u20131034","journal-title":"J Urol"},{"key":"6139_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13054-015-0930-9","volume":"19","author":"D Faraoni","year":"2015","unstructured":"Faraoni D, Levy JH, Albaladejo P et al (2015) Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care 19:203","journal-title":"Crit Care"},{"key":"6139_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","volume":"69","author":"JU Doherty","year":"2017","unstructured":"Doherty JU, Gluckman TJ, Hucker WJ et al (2017) 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American college of cardiology clinical expert consensus document task force. J Am Coll Cardiol 69:871\u2013898","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6139_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/end.2022.0390","volume":"37","author":"M Babar","year":"2023","unstructured":"Babar M, Loloi J, Azhar U, Tang K, Ines M, Singh S, Iqbal N, Ciatto M (2023) Water vapour thermal therapy (Rezum) outcomes at 4 years in relation to the number of injections: is the less is more treatment approach durable? J Endourol 37(2):157\u2013164. https:\/\/doi.org\/10.1089\/end.2022.0390","journal-title":"J Endourol"},{"issue":"1","key":"6139_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00345-024-04823-7","volume":"42","author":"M Coscarella","year":"2024","unstructured":"Coscarella M, Al Barajraji M, Moussa I, Hombert L, Naudin M, Roumegu\u00e8re T et al (2024) Predicting the risk of failed trial without catheter following Rez\u016bm\u2122 therapy: results from a multicenter analysis. World J Urol 42(1):129. https:\/\/doi.org\/10.1007\/s00345-024-04823-7","journal-title":"World J Urol"},{"issue":"1","key":"6139_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12894-023-01237-2","volume":"23","author":"J Yang","year":"2023","unstructured":"Yang J, Wu W, Amier Y, Li X, Wan W, Liu C, Zhang Y, Yu X (2023) Efficacy and safety of water vapor thermal therapy in the treatment of benign prostatic hyperplasia: a systematic review and single-arm meta-analysis. BMC Urol 23(1):72. https:\/\/doi.org\/10.1186\/s12894-023-01237-2","journal-title":"BMC Urol"},{"issue":"1","key":"6139_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eururo.2021.02.008","volume":"80","author":"D Abt","year":"2021","unstructured":"Abt D, M\u00fcllhaupt G, Hechelhammer L, Markart S, G\u00fcsewell S, Kessler TM, Schmid HP, Engeler DS, Mordasini L (2021) Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2\u2013year outcomes of a randomised, open\u2013label, single\u2013centre trial. Eur Urol 80(1):34\u201342. https:\/\/doi.org\/10.1016\/j.eururo.2021.02.008","journal-title":"Eur Urol"},{"issue":"3","key":"6139_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41391-024-00833-z","volume":"27","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA, Moss JL, Freedman SJ (2024) Two-year long-term follow-up of treatment with the optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study). Prostate Cancer Prostatic Dis 27(3):531\u2013536. https:\/\/doi.org\/10.1038\/s41391-024-00833-zEpub 2024 Apr 29. PMID: 38684918; PMCID: PMC11319191","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"24","key":"6139_CR35","doi-asserted-by":"publisher","first-page":"00267","DOI":"10.1016\/j.euf.2024.12.012","volume":"S2405\u20134569","author":"D Elterman","year":"2025","unstructured":"Elterman D, Kaplan SA (2025) Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new approach to first-line interventional therapy. Eur Urol Focus S2405\u20134569(24):00267\u201300260. https:\/\/doi.org\/10.1016\/j.euf.2024.12.012","journal-title":"Eur Urol Focus"},{"issue":"5S","key":"6139_CR36","doi-asserted-by":"publisher","first-page":"e755","DOI":"10.1097\/01.JU.0001008668.53858.38.07","volume":"211","author":"HJ Lee","year":"2024","unstructured":"Lee HJ, Lim B, Sundaram P, Chan T, Neo SH, Cheng C et al (2024) MP46-07 outcomes of Rez\u016bm water vapour thermal therapy for patients on oral antiplatelet or anticoagulants. J Urol 211(5S):e755. https:\/\/doi.org\/10.1097\/01.JU.0001008668.53858.38.07","journal-title":"J Urol"},{"key":"6139_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876\u2013892","journal-title":"Eur Urol"},{"issue":"10","key":"6139_CR38","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1007\/s00345-023-04652-3","volume":"41","author":"M Babar","year":"2023","unstructured":"Babar M, Loloi J, Azhar U, Tang K, Ines M, Singh S, Iqbal N, Ciatto M (2023) Rez\u016bm outcomes in relation to the number of injections: is less more? World J Urol 41(10):2747\u20132754. https:\/\/doi.org\/10.1007\/s00345-023-04652-3","journal-title":"World J Urol"},{"key":"6139_CR39","doi-asserted-by":"publisher","unstructured":"Schwartzmann I, Secco S, Farr\u00e9 A, Garc\u00eda-Barreras S, Fern\u00e1ndez E, D\u2019Anna M, Cindolo L, Parejo V, Tornero JI, Ferrari G, Varvello F, de Ponce J, Povo I (2025) Injection density in Rez\u016bm\u00ae: Less might not be more. A multicentric international study. Actas Urol Esp (Engl Ed). ;49(7):501824. English, Spanish. https:\/\/doi.org\/10.1016\/j.acuroe.2025.501824. Epub 2025 Jul 31. PMID: 40752731","DOI":"10.1016\/j.acuroe.2025.501824"},{"issue":"6","key":"6139_CR40","first-page":"10480","volume":"27","author":"L Glick","year":"2020","unstructured":"Glick L, Chandrasekar T, Hubosky SG, Teplitsky S, Shah M, Leong JY, Ouma G, Mark JR (2020) How I do it: anticoagulation management for common urologic procedures. Can J Urol 27(6):10480\u201310487","journal-title":"Can J Urol"},{"key":"6139_CR41","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/ALN.0b013e318289bcba","volume":"118","author":"JH Levy","year":"2013","unstructured":"Levy JH, Faraoni D, Spring JL et al (2013) Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology 118:1466\u20131474","journal-title":"Anesthesiology"},{"issue":"22","key":"6139_CR42","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.3390\/jcm13226842","volume":"13","author":"A Rodrigues","year":"2024","unstructured":"Rodrigues A, Gon\u00e7alves LR, Greg\u00f3rio T, Baldaia C, Santo GC, Gouveia J (2024) Urgent reversal of direct oral anticoagulants in critical and life-threatening bleeding: a multidisciplinary expert consensus. J Clin Med 13(22):6842. https:\/\/doi.org\/10.3390\/jcm13226842","journal-title":"J Clin Med"},{"key":"6139_CR43","unstructured":"U.S. Food and Drug Administration. FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/0761025Orig1000TOC.cfm. Accessed October (2015)"},{"issue":"11","key":"6139_CR44","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00345-020-03078-2","volume":"38","author":"K Dimitropoulos","year":"2020","unstructured":"Dimitropoulos K, Omar MI, Chalkias A, Arnaoutoglou E, Douketis J, Gravas S (2020) Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines. World J Urol 38(11):2761\u20132770. https:\/\/doi.org\/10.1007\/s00345-020-03078-2","journal-title":"World J Urol"},{"key":"6139_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.crad.2012.08.005","volume":"67","author":"R Chowdhury","year":"2012","unstructured":"Chowdhury R, Abbas A, Idriz S et al (2012) Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. Clin Radiol 67:64\u201370","journal-title":"Clin Radiol"},{"key":"6139_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.crad.2004.10.014","volume":"60","author":"CU Ihezue","year":"2005","unstructured":"Ihezue CU, Smart J, Dewbury KC et al (2005) Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60:459\u2013463","journal-title":"Clin Radiol"},{"key":"6139_CR47","unstructured":"Saito K et al Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and\/or anticoagulation therapy. [Details not provided]."},{"issue":"12","key":"6139_CR48","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1111\/jth.15896","volume":"20","author":"TF Wang","year":"2022","unstructured":"Wang TF, Sanfilippo KM, Douketis J, Falanga A, Karageorgiou J, Maraveyas A, Ortel TL, Soff G, Vedantham S, Zwicker JI et al (2022) Peri\u2013procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: guidance from the SSC of the ISTH. J Thromb Haemost 20(12):3026\u20133038. https:\/\/doi.org\/10.1111\/jth.15896","journal-title":"J Thromb Haemost"},{"key":"6139_CR49","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, Willems S, Gerstenfeld EP et al (2017) Uninterrupted Dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med 376:1627\u20131636","journal-title":"N Engl J Med"},{"key":"6139_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","volume":"126","author":"JS Healey","year":"2012","unstructured":"Healey JS, Eikelboom J, Douketis J et al (2012) Periprocedural bleeding and thromboembolic events with Dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation 126:343\u2013348","journal-title":"Circulation"},{"key":"6139_CR51","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1160\/TH14-04-0305","volume":"113","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Healey JS, Brueckmann M et al (2015) Perioperative bridging anticoagulation during Dabigatran or warfarin interruption among patients who had an elective surgery or procedure: substudy of the RE-LY trial. Thromb Haemost 113:625\u2013632","journal-title":"Thromb Haemost"},{"key":"6139_CR52","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA et al (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 368:2084\u20132093","journal-title":"N Engl J Med"},{"key":"6139_CR53","first-page":"1163","volume":"175","author":"NP Clark","year":"2015","unstructured":"Clark NP, Witt DM, Davies LE et al (2015) Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures. JAMA 175:1163\u20131168","journal-title":"JAMA"},{"key":"6139_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1501035","volume":"373","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S et al (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373:823\u2013833","journal-title":"N Engl J Med"},{"issue":"14","key":"6139_CR55","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.jacc.2017.10.052","volume":"72","author":"FM Kusumoto","year":"2017","unstructured":"Kusumoto FM, Bailey KR, Chaouki AS et al (2017) Systematic review for the 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 72(14):1653\u20131676","journal-title":"J Am Coll Cardiol"},{"key":"6139_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2018.0374","volume":"153","author":"A Verma","year":"2018","unstructured":"Verma A, Ha ACT, Rutka JT et al (2018) What surgeons should know about non-vitamin K oral anticoagulants: A review. JAMA Surg 153:577\u2013585","journal-title":"JAMA Surg"},{"key":"6139_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.annfar.2013.04.016","volume":"32","author":"G Pernod","year":"2013","unstructured":"Pernod G, Albaladejo P, Godier A et al (2013) Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Ann Fr Anesth Reanim 32:691\u2013700","journal-title":"Ann Fr Anesth Reanim"},{"key":"6139_CR58","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","volume":"104","author":"P Sie","year":"2011","unstructured":"Sie P, Samama CM, Godier A et al (2011) Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors: recommendations of the working group on perioperative haemostasis and the French study group on thrombosis and haemostasis. Arch Cardiovasc Dis 104:669\u2013676","journal-title":"Arch Cardiovasc Dis"},{"key":"6139_CR59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/imj.12448","volume":"44","author":"H Tran","year":"2014","unstructured":"Tran H, Joseph J, Young L et al (2014) New oral anticoagulants: A practical guide on prescription, laboratory testing, and peri-procedural\/bleeding management. Intern Med J 44:525\u2013536","journal-title":"Intern Med J"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06139-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:44:04Z","timestamp":1765953844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06139-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6139"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06139-6","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no Conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"52"}}